IXC 5.56% 7.6¢ invex therapeutics ltd

Ann: Quarterly Report and Appendix 4C with appendix, page-3

  1. 343 Posts.
    lightbulb Created with Sketch. 23
    I agree, concise, straight to the point.
    Top management team. Risks are understood with regards trials and being a single product keeps the team focused also. Drug is safe. Manufacturing/commercialisation risks will be understood down the track.
    It's a low key, quality stock with a tight register and it's going to go up in multiples. I'm buying.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
0.004(5.56%)
Mkt cap ! $5.711M
Open High Low Value Volume
7.5¢ 7.6¢ 7.5¢ $167 2.216K

Buyers (Bids)

No. Vol. Price($)
1 40000 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 4000 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.